Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 6.56
-0.35 (-5.07%)
Jul 30, 2026, 3:04 PM CST
SHE:002412 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,033 | 1,039 | 1,004 | 955.53 | 916.06 | 891.84 |
Revenue Growth | 1.27% | 3.41% | 5.12% | 4.31% | 2.72% | 20.32% |
Gross Profit Gross Profit Growth | 799.87 | 797.38 | 754.2 | 692.75 | 648.69 | 634.88 |
Operating Income Operating Income Growth | 228.95 | 238.16 | 236.33 | 173.2 | 133.23 | 126.13 |
Net Income Net Income Growth | 225.27 | 198.12 | 220.24 | 205.01 | 167.62 | 134.85 |
Earnings Per Share EPS Growth | 0.45 | 0.39 | 0.44 | 0.41 | 0.33 | 0.27 |
EPS Growth | 29.93% | -10.05% | 7.44% | 22.31% | 24.29% | 27.07% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 1,038 | 1,003 | 953.48 | 912.38 | 890.33 |
Unallocated Others Unallocated Others Growth | 0.98 | 1.08 | 2.05 | 3.68 | 1.5 |
Total Total Growth | 1,039 | 1,004 | 955.53 | 916.06 | 891.84 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 570.93 | 583.45 | 372.14 | 255 | 281.23 | 139.55 |
Total Debt Total Debt Growth | 50.98 | 57.5 | 84.51 | 95.12 | 120.15 | 131.79 |
Net Cash (Debt) Net Cash Growth | 519.95 | 525.95 | 287.63 | 159.88 | 161.08 | 7.76 |
Net Cash Growth | 55.29% | 82.86% | 79.90% | -0.74% | 1975.89% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.03 | 1.05 | 0.57 | 0.32 | 0.32 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 185.55 | 245.38 | 130.78 | 160.95 | 143.81 | 212.54 |
Capital Expenditures CapEx Growth | -9.99 | -11.1 | -11.64 | -19.48 | -11.5 | -229.34 |
Free Cash Flow Free Cash Flow Growth | 175.56 | 234.28 | 119.15 | 141.47 | 132.3 | -16.8 |
Free Cash Flow Growth | 18.20% | 96.63% | -15.78% | 6.93% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 77.45% | 76.76% | 75.08% | 72.50% | 70.81% | 71.19% |
Operating Margin | 22.17% | 22.93% | 23.53% | 18.13% | 14.54% | 14.14% |
Pretax Margin | 25.65% | 22.97% | 25.16% | 23.65% | 19.85% | 16.81% |
Profit Margin | 21.81% | 19.07% | 21.93% | 21.46% | 18.30% | 15.12% |
FCF Margin | 17.00% | 22.55% | 11.86% | 14.80% | 14.44% | -1.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | - | - | 0.300 |
Dividend Per Share Growth | 0% | - | - | - | - |
Dividend Yield | 4.29% | 4.90% | - | - | 5.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 15.44 | 16.28 | 13.73 | 16.64 | 18.40 | 23.70 |
Forward PE | - | 15.12 | 15.12 | 15.12 | 15.12 | 15.12 |
P/FCF Ratio | 19.81 | 13.77 | 25.38 | 24.12 | 23.32 | - |
PS Ratio | 3.37 | 3.11 | 3.01 | 3.57 | 3.37 | 3.58 |